Literature DB >> 19076658

Epidemiology and biology of menstrual migraine.

Vincent T Martin1, Richard B Lipton.   

Abstract

Migraine is frequently associated with menstruation in female migraineurs, and consequently it is commonly referred to as menstrually associated migraine. The trigger thought to be partially responsible for menstrually associated migraine is a significant drop in circulating estrogen that is noted during 2-3 days prior to onset of menses. It is estimated that approximately 50% of women have an increased risk of experiencing migraine during the premenstrual phase of decreasing estrogen levels. Understanding the biological basis of migraine associated with menses will facilitate an accurate diagnosis and help patients recognize time susceptible to migraine exacerbations. This paper will review the biological bases for the hormonal changes that occur during the menstrual cycle and review the prevalence and burden of menstrual migraine among female headache sufferers.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19076658     DOI: 10.1111/j.1526-4610.2008.01310.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  30 in total

Review 1.  Hormonal contraception and migraine: clinical considerations.

Authors:  Stephanie S Faubion; Petra M Casey; Lynne T Shuster
Journal:  Curr Pain Headache Rep       Date:  2012-10

2.  Migraine and subsequent risk of breast cancer: a prospective cohort study.

Authors:  Anke C Winter; Kathryn M Rexrode; I-Min Lee; Julie E Buring; Rulla M Tamimi; Tobias Kurth
Journal:  Cancer Causes Control       Date:  2012-11-10       Impact factor: 2.506

Review 3.  Perimenstrual headache in adolescence.

Authors:  Andrew D Hershey
Journal:  Curr Pain Headache Rep       Date:  2012-10

4.  Hormonal manipulation strategies in the management of menstrual migraine and other hormonally related headaches.

Authors:  Lynne T Shuster; Stephanie S Faubion; Richa Sood; Petra M Casey
Journal:  Curr Neurol Neurosci Rep       Date:  2011-04       Impact factor: 5.081

5.  Migraine history, nonsteroidal anti-inflammatory drug use, and risk of postmenopausal endometrial cancer.

Authors:  Amanda I Phipps; Garnet L Anderson; Barbara B Cochrane; Christopher I Li; Jean Wactawski-Wende; Gloria Y F Ho; Mary Jo O'Sullivan; Polly A Newcomb
Journal:  Horm Cancer       Date:  2012-07-24       Impact factor: 3.869

Review 6.  Comorbidity in perimenstrual migraine.

Authors:  Marianna Nicodemo; Sabina Cevoli; Giulia Giannini; Pietro Cortelli
Journal:  Curr Pain Headache Rep       Date:  2012-10

7.  A review of the use of frovatriptan in the treatment of menstrually related migraine.

Authors:  Gianni Allais; Chiara Benedetto
Journal:  Ther Adv Neurol Disord       Date:  2013-03       Impact factor: 6.570

8.  Prevention of episodic migraines with topiramate: results from a non-interventional study in a general practice setting.

Authors:  Gereon Nelles; Lukas Schmitt; Thomas Humbert; Veit Becker; Petra Sandow; Karin Bornhoevd; Dirk Fritzsche; Barbara Schäuble
Journal:  J Headache Pain       Date:  2009-11-06       Impact factor: 7.277

9.  Estrous cycle-dependent neurovascular dysfunction induced by angiotensin II in the mouse neocortex.

Authors:  Carmen Capone; Josef Anrather; Teresa A Milner; Costantino Iadecola
Journal:  Hypertension       Date:  2009-06-08       Impact factor: 10.190

10.  The association of migraine with menstrually related mood disorders and childhood sexual abuse.

Authors:  Adomas Bunevicius; David R Rubinow; Anne Calhoun; Jane Leserman; Erin Richardson; Kim Rozanski; Susan S Girdler
Journal:  J Womens Health (Larchmt)       Date:  2013-08-09       Impact factor: 2.681

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.